The role of positron emission tomography in the drug development of M100907, a putative antipsychotic with a novel mechanism of action

被引：19

作者：

Offord, SJ

Wong, DF

Nyberg, S

机构：

[1] Hoechst Marion Roussel Inc, Global Mkt, Bridgewater, NJ 08807 USA

[2] Johns Hopkins Med Inst, Dept Radiol, Div Nucl Med, Baltimore, MD 21205 USA

[3] Karolinska Inst, Dept Clin Neurosci, Psychiat Sect, Stockholm, Sweden

来源：

关键词：

D O I：

10.1002/j.1552-4604.1999.tb05933.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：17S / 24S

页数：8

共 26 条

[1] Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain
Andrée, B
Nyberg, S
Ito, H
Ginovart, N
Brunner, F
Jaquet, F
Halldin, C
Farde, L
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (04) : 317 - 323
[2] [Anonymous], 1993, AM J PSYCHIAT, V150, P1
[3] BRUNNERFERBER F, 1998, EUR NEUROPSYCHOPH S2, V8
[4] IMPORTANT ISSUES IN THE DRUG-TREATMENT OF SCHIZOPHRENIA
DAVIS, JM
SCHAFFER, CB
KILLIAN, GA
KINARD, C
CHAN, C
[J]. SCHIZOPHRENIA BULLETIN, 1980, 6 (01) : 70 - 87
[5] DELAY J, 1952, Ann Med Psychol (Paris), V110, P112
[6] DIMASI JA, 1995, DRUG INF J, V29, P375
[7] The advantage of using positron emission tomography in drug research
Farde, L
[J]. TRENDS IN NEUROSCIENCES, 1996, 19 (06) : 211 - 214
[8] Grunder G, 1997, NEUROPSYCHOPHARMACOL, V17, P175
[9] THE HISTORY OF CLOZAPINE
HIPPIUS, H
[J]. PSYCHOPHARMACOLOGY, 1989, 99 : S3 - S5
[10] KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789